Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|March 11, 2014
Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancerRobert J Myerson, Benjamin Tan, Steven Hunt, et al.Cancer Chemotherapy and Pharmacology|June 12, 2014
A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignanciesAndrea Wang-Gillam, Nilay Thakkar, A Craig Lockhart, et al.Cancer Discovery|February 8, 2020
Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i> <sup>V600</sup>-Mutant Non-Melanoma CancersVivek Subbiah, Igor Puzanov, Jean-Yves Blay, et al.JAMA Oncology|May 30, 2020
FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical TrialHaeseong Park, Ramon U Jin, Andrea Wang-Gillam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumorsA Craig Lockhart, Mace L Rothenberg, Jakob Dupont, et al.Journal of Cancer Therapy|October 4, 2013
A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal AdenocarcinomaDominic E Sanford, Matthew R Porembka, Roheena Z Panni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapyLeonard B Saltz, Lee S Rosen, John L Marshall, et al.NPJ Precision Oncology|September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancerJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.JAMA Oncology|December 21, 2018
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 StudyManish A Shah, Takashi Kojima, Daniel Hochhauser, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2018
BRAF Inhibition in <i>BRAF</i><sup>V600</sup>-Mutant Gliomas: Results From the VE-BASKET StudyThomas Kaley, Mehdi Touat, Vivek Subbiah, et al.Pageof 10